Introduction
Definition of abetalipoproteinemia
Overview of the condition
Abetalipoproteinemia (ABL), also known as Bassen-Kornzweig syndrome, is a rare autosomal recessive disorder marked by low or absent levels of plasma cholesterol, low-density lipoproteins (LDLs), and very-low-density lipoproteins (VLDLs).1,2
Genetic basis and rarity
The condition is caused by a homozygous autosomal recessive mutation in the MTTP gene, which encodes the microsomal triglyceride protein (MTP) that mediates intracellular chylomicron. Abetalipoproteinemia occurs in less than 1 in 1 million persons. It is extremely rare.1,2,3
Importance of studying its impact on quality of life
Physical health implication
This disorder typically shows from infancy, these manifestations include vomiting, diarrhoea, and malabsorption of fat. Malabsorption of fat-soluble vitamins can lead to a range of clinical manifestations like anaemia, acanthocytosis, progressive loss of night and colour vision, and other neuromuscular symptoms. Without proper management, these symptoms can severely affect an individual’s physical health.1,2,3
Physical health Impact
Nutritional deficiencies
Fat-soluble vitamins (A, D, E, K)
ABL leads to severe deficiencies in fat-soluble vitamins, particularly vitamins A, D, E, and K. This is due to the inability to properly absorb and transport these vitamins, which require apoB-containing lipoproteins to absorb and transport to peripheral tissues.1,4
Effects of deficiencies
- Vision problems: Vitamin A deficiency can lead to retinitis pigmentosa, night blindness, and other visual impairments
- Bone health issues: Vitamin D deficiency affects bone mineralisation, leading to rickets in children and osteomalacia in adults
- Bleeding tendencies: Vitamin K deficiency can lead to bleeding and bruising
- Neuromuscular symptoms: Vitamin E deficiency results in peripheral neuropathy, spinocerebellar ataxia, and muscle weakness1,4
Gastrointestinal symptoms
Chronic diarrhoea
Patients with ABL tend to suffer from chronic diarrhoea due to fat malabsorption. The lack of proper lipoprotein formation results in the inability to digest, and absorb, dietary fats.2,4
Steatorrhea (fatty stools)
Steatorrhea is another common symptom, characterised by fatty stools that occur because of undigested fats passing through the gastrointestinal tract. This condition is a direct result of impaired lipid absorption.2,4
Neurological complications
Peripheral neuropathy
Peripheral neuropathy is a frequent complication in ABL patients, mainly due to vitamin E deficiency. This condition involves damage to the peripheral nerves, causing symptoms, such as numbness, tingling, and pain in the extremities.1,2
Ataxia and muscle weakness
Ataxia, or lack of muscle coordination, along with muscle weakness, are significant issues resulting from the same vitamin E deficiency. These neurological symptoms can severely impact mobility and overall quality of life, often leading to progressive disability if left untreated.1,2
Cardiovascular issues
Impact on lipid levels
Patients with ABL exhibit markedly low levels of plasma lipids, including total cholesterol, HDL, LDL, and triglycerides. This profound hypolipidemia is due to the absence or severe reduction of apoB-containing lipoproteins.1,4
Potential for long-term heart problems
While low lipid levels might suggest a reduced risk of atherosclerosis, the overall impact on cardiovascular health is still unclear. The long-term deficiency in essential fatty acids and fat-soluble vitamins may contribute to other cardiovascular issues, calling for careful monitoring and management.1
Emotional and psychological impact
Anxiety and depression
Coping with chronic illness
Patients with abetalipoproteinemia (ABL) go through significant challenges; this is because of the chronic nature of their illness. The lifelong need for dietary modifications and high-dose vitamin supplementation can be overwhelming and lead to substantial psychological stress. The need for ongoing medical supervision and frequent health assessments adds to his burden, making daily life a continuous struggle against the illness.1,4
Fear of complications
The potential for severe complications such as neurological impairments and gastrointestinal issues contributes to heightened anxiety. Patients live with the constant fear of progressive symptoms, including the risk of becoming wheelchair-bound or bedridden due to untreated neuromuscular symptoms. This fear is worsened by the knowledge that, without early, and adequate treatment, life expectancy may be significantly reduced.1,4
Impact on self-esteem
Physical limitations
The physical limitations imposed by ABL, such as muscular weakness and other neuromuscular symptoms, can severely affect self-esteem. Patients tend to struggle with daily activities and may require extra assistance, which can lead to feelings of helplessness and dependency. The progressive nature of these physical limitations can further reduce self-worth and lead to negative self-image.5
Social stigma or isolation
Social interactions can be affected by the visible symptoms of ABL, such as difficulty in movement or speech due to neuromuscular impairments. This can lead to social stigma and isolation, as patients might withdraw from social activities to avoid being judged or negatively embarrassed by others. The resultant isolation can worsen feelings of loneliness and depression, further impacting their emotional well-being.1,5
Social and lifestyle impact
Daily living challenges
Dietary restrictions and management
Patients with ABL have to follow specific dietary modifications, which include avoiding long-chain fatty acids and ensuring appropriate intake of fat-soluble vitamins A, D, E and K through supplements. Managing this diet is important to prevent nutritional deficiencies and associated complications.1
Regular medical appointments and treatments
The need for regular medical follow-ups is essential for monitoring health status and managing complications. Frequent visits to healthcare providers for routine check-ups, blood tests, and assessments of vitamin levels are necessary to maintain health and manage symptoms effectively.5
Impact on education and career
Absences from school or work
Going for regular medical appointments, symptom management, and hospitalisations can lead to frequent absences from school or work. This can affect academic performance and career advancement.5
Limitations in career choices
Physical limitations and the need for a controlled environment to manage dietary and health requirements may restrict career options. Leading to choosing careers that offer flexibility and accommodate their health needs.1,5
Family dynamics
Caregiver burden
The need for constant support and care can significantly burden family members, affecting their emotional and physical well-being. Caregivers often have to assist with dietary management, medication administration, and transportation to medical appointments.5
Family planning considerations
Families affected by ABL should consider genetic counselling, as it helps in understanding the risks of passing the condition on to offspring and making informed decisions about family planning.1
Strategies for managing quality of life
Medical management
Regular monitoring and treatment
Continuous monitoring of vitamin levels and overall health status is essential. Regular treatment plans, including vitamin supplementation and management of gastrointestinal symptoms, help in mitigating complications.1
Supplementation and dietary adjustments
Ensuring adequate supplementation and adherence to dietary guidelines are vital for managing symptoms and preventing deficiencies.1
Psychological support
Counselling and therapy
Professional psychological support, including counselling and therapy, can help patients and their families cope with the emotional stress associated with chronic illness.1,5
Support groups and networks
Participating in support groups provides a platform for sharing experiences and obtaining emotional support from others going through similar challenges.1
Lifestyle modifications
Exercise and physical therapy
Doing regular exercise and physical therapy can help maintain muscle strength and coordination, mitigating some neurological symptoms linked with ABL.1
Adaptive techniques for daily activities
Implementing adaptive daily routines can help patients manage their activities more efficiently and independently. 1
Future directions and research
Advances in treatment options
Gene therapy
Emerging research in gene therapy offers the potential for correcting genetic defects associated with ABL, providing hope for more effective long-term treatments.1
New medication developments
Ongoing research into new medications aims to improve the management of ABL and reduce its complications.1
Need for comprehensive care approaches
Multidisciplinary teams
A multidisciplinary approach involving different healthcare professionals ensures holistic care, addressing all aspects of the patient’s health and well-being.1,5
Patient-centred care models
Emphasising patient-centred care, which focuses on individual needs and preferences, is crucial for improving the quality of life for patients with ABL.1
Importance of patient education and advocacy
Educating patients and advocating for their needs is important for effective disease management.1
- Patient Education: Providing comprehensive information about the condition, dietary requirements, and management strategies empowers patients to take an active role in their care
- Advocacy: efforts aim to raise awareness about ABL, promote research, and ensure access to necessary medical and support services
Summary
- Mutations in the MTTP gene cause the rare autosomal recessive disorder abetalipoproteinemia (ABL). Leading to multiple health complications
- This disorder necessitates strict dietary management and continuous medical supervision to prevent malabsorption and deficiency of fat-soluble vitamins, leading to significant physical, emotional, and social challenges
- Holistic care, encompassing medical management, psychological support, and lifestyle adjustments, is essential to improving quality of life
- Future research, including gene therapy and new medications, offers hope for more effective treatments, while comprehensive patient education and advocacy remain crucial
References
- Burnett JR, Hooper AJ, Hegele RA. Abetalipoproteinemia. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, et al., editors. GeneReviews®. Seattle (WA): University of Washington, Seattle; 1993. Available from: http://www.ncbi.nlm.nih.gov/books/NBK532447/
- Barakizou H, Gannouni S, Messaoui K, Difilippo M, Sassolas A, Bayoudh F. Abetalipoproteinemia: A novel mutation of microsomal triglyceride transfer protein (MTP) gene in a young Tunisian patient. Egyptian Journal of Medical Human Genetics [Internet]. 2016 [cited 2024 Dec 17]; 17(3):251–4. Available from: https://www.sciencedirect.com/science/article/pii/S1110863015001263.
- Najafi Sani M, Sabbaghian M, Mahjoob F, Cefalù AB, Averna MR, Rezaei N. Identification of a novel mutation of MTP gene in a patient with abetalipoproteinemia. Ann Hepatol [Internet]. 2011 [cited 2024 Dec 17]; 10(2):221–6. Available from: http://www.elsevier.es/en-revista-annals-hepatology-16-articulo-identification-novel-mutation-mtp-gene-S166526811931573X.
- Zamel R, Khan R, Pollex RL, Hegele RA. Abetalipoproteinemia: two case reports and literature review. Orphanet Journal of Rare Diseases. 2008 Jul 8;3(1):19. Available from: https://doi.org/10.1186/1750-1172-3-19
- Bogart K, Hemmesch A, Barnes E, Blissenbach T, Beisang A, Engel P, et al. Healthcare access, satisfaction, and health-related quality of life among children and adults with rare diseases. Orphanet Journal of Rare Diseases [Internet]. 2022 [cited 2024 Dec 18]; 17(1):196. Available from: https://doi.org/10.1186/s13023-022-02343-4.

